| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Sep-07 | | Total Revenue | 600,294 | 799,199 | 1,013,349 | 904,866 | | Cost of Revenue | 522,687 | 650,009 | 812,503 | 627,474 | | | Gross Profit | 77,607 | 149,190 | 200,846 | 277,392 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 81,436 | 88,620 | 74,790 | 68,634 | | Non Recurring | (2,503) | 244,999 | (2,530) | (5,543) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,326) | (184,429) | 128,586 | 214,301 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (280) | (821) | (2,871) | (947) | | Earnings Before Interest And Taxes | (1,606) | (185,250) | 125,432 | 213,354 | | Interest Expense | 43,919 | 46,583 | 44,578 | 6,498 | | Income Before Tax | (45,525) | (231,833) | 80,854 | 206,856 | | Income Tax Expense | (13,270) | (14,641) | 21,038 | 62,929 | | Minority Interest |
-
|
-
| (283) |
-
| | | | Net Income From Continuing Ops | (32,255) | (217,192) | 59,816 | 143,927 | | | Non-recurring Events | | Discontinued Operations | (525) | (661) | (766) | (8,515) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (32,780) | (217,853) | 59,050 | 135,412 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($32,780) | ($217,853) | $59,050 | $135,412 |
|
0.45% Nasdaq 
0.20%
Income Statement
